title: Mechanism of Human Nucleocytoplasmic Hexosaminidase D.
abstract: Mammalian β-hexosaminidases have been shown to play essential roles in cellular physiology and health. These enzymes are responsible for the cleavage of the monosaccharides N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) from cellular substrates. One of these β-hexosaminidases, hexosaminidase D (HexD), encoded by the HEXDC gene, has received little attention. No mechanistic studies have focused on the role of this unusual nucleocytoplasmically localized β-hexosaminidase, and its cellular function remains unknown. Using a series of kinetic and mechanistic investigations into HexD, we define the precise catalytic mechanism of this enzyme and establish the identities of key enzymic residues. The preparation of synthetic aryl N-acetylgalactosaminide substrates for HexD in combination with measurements of kinetic parameters for wild-type and mutant enzymes, linear free energy analyses of the enzyme-catalyzed hydrolysis of these substrates, evaluation of the reaction by nuclear magnetic resonance, and inhibition studies collectively reveal the detailed mechanism of action employed by HexD. HexD is a retaining glycosidase that operates using a substrate-assisted catalytic mechanism, has a preference for galactosaminide over glucosaminide substrates, and shows a pH optimum in its second-order rate constant at pH 6.5-7.0. The catalytically important residues are Asp148 and Glu149, with Glu149 serving as the general acid/base residue and Asp148 as the polarizing residue. HexD is inhibited by Gal-NAG-thiazoline (Ki = 420 nM). The fundamental insights gained from this study will aid in the development of potent and selective probes for HexD, which will serve as useful tools to improve our understanding of the physiological role played by this unusual enzyme.
authors.affiliation: Department of Chemistry, Simon Fraser University , 8888 University Drive, Burnaby, BC V5A 1S6, Canada.|Biomedical Sciences Research Complex, University of St Andrews , North Haugh, St Andrews, Fife KY16 9ST, U.K.
authors.forename: Matthew G
authors.initials: MG
authors.lastname: Alteen
authors.affiliation: Biomedical Sciences Research Complex, University of St Andrews , North Haugh, St Andrews, Fife KY16 9ST, U.K.
authors.forename: Verena
authors.initials: V
authors.lastname: Oehler
authors.affiliation: Department für Chemie, Universität für Bodenkultur , Muthgasse 18, A-1190 Wien, Austria.
authors.forename: Ivana
authors.initials: I
authors.lastname: Nemčovičová
authors.affiliation: Department für Chemie, Universität für Bodenkultur , Muthgasse 18, A-1190 Wien, Austria.
authors.forename: Iain B H
authors.initials: IB
authors.lastname: Wilson
authors.affiliation: Department of Chemistry, Simon Fraser University , 8888 University Drive, Burnaby, BC V5A 1S6, Canada.
authors.forename: David J
authors.initials: DJ
authors.lastname: Vocadlo
authors.affiliation: Biomedical Sciences Research Complex, University of St Andrews , North Haugh, St Andrews, Fife KY16 9ST, U.K.
authors.forename: Tracey M
authors.initials: TM
authors.lastname: Gloster
mesh_terms: D002384:Catalysis; D004791:Enzyme Inhibitors / Q000737:chemistry*; D006596:Hexosaminidases / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007700:Kinetics; D053778:Thiazolidines / Q000737:chemistry*
chemical_list: D004791:Enzyme Inhibitors; D053778:Thiazolidines; D006596:Hexosaminidases